US Patent Issued to Eli Lilly and Co. on Sept. 30 for "Sodium-hydrogen exchanger 3 inhibitor compounds" (Indiana, Virginia Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,428,377, issued on Sept. 30, was assigned to Eli Lilly and Co. (Indianapolis).

"Sodium-hydrogen exchanger 3 inhibitor compounds" was invented by Kostas Gavardinas (Carmel, Ind.), Prabhakar Jadhav (Chantilly, Va.), Xiaojun Wang (Carmel, Ind.) and John Rowley Wetterau (Indianapolis).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to sodium-hydrogen exchanger 3 (NHE3) inhibitor compounds of the Formula:to pharmaceutical compositions comprising the compound and to the use of the compound for the treatment of certain diseases associated with elevated sodium and/or phosphate levels."

The patent was filed on May 8, 2020, under App...